首页> 外文期刊>Annals of King Edward Medical University. >Superficial Parotidectomy and Extracapsular Dissection as Part of Surgeon's Armamentarium for Benign Parotid Tumors: A Clinical Trial
【24h】

Superficial Parotidectomy and Extracapsular Dissection as Part of Surgeon's Armamentarium for Benign Parotid Tumors: A Clinical Trial

机译:作为良性腮腺肿瘤的外科医生阿菌肿瘤的浅腮腺切向术和折射率解剖:临床试验

获取原文
           

摘要

Background: Superficial Parotidectomy (SP) has been considered the standard treatment for benign parotid tumors. In recent years, extracapsular dissection (ECD) is gaining popularity. Literature addressing the comparison of these techniques is limited. Objective: To compare SP and ECD among patients with single, mobile, benign tumor in superficial lobe of parotid gland. Methodology: This randomized trial conducted in King Edward Medical University, Lahore from 2015 to 2018 included patients with solitary, mobile tumor in superficial parotid lobe using non-probability purposive sampling. FNAC confirmed benign tumor and MRI demarcated tumor extent. The patients were randomized for SP or ECD. Post-operatively, the patients were followed up to detect adverse effects and recurrence. Data was analyzed using SPSS 26.0. T-test and Fischer exact test were used considering p-value
机译:背景:浅表腮腺切除术(SP)被认为是良性腮腺肿瘤的标准治疗。近年来,额外的解剖(ECD)越来越受欢迎。寻址这些技术的比较有限的文献。目的:比较腮腺浅层叶片患者患者的SP和ECD。方法论:在爱德华王医科大学进行的这种随机试验,从2015年到2018年在2015年到2018年,患有孤立,流动肿瘤的患者,使用非概率用目的采样。 FNAC确认良性肿瘤和MRI划定的肿瘤程度。患者随机为SP或ECD。可操作性地,随访患者以检测不良影响和复发。使用SPSS 26.0分析数据。考虑P值,使用T-Test和Fischer精确测试

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号